Fierce Biotech January 4, 2024
Nalu Medical has collected $65 million in new financing to boost the reach and adoption of its miniaturized neurostimulation implant aimed at treating chronic pain.
The California-based company’s series E round was led by a new backer in Novo Holdings; returning investors included Gilde Healthcare, MVM Partners, Endeavor Vision, Decheng Capital, Longitude Capital, Advent Life Sciences, Pura Vida and Aperture Venture Partners.
Nalu’s FDA-cleared approach includes a small, battery-free pulse generator that’s placed under the skin through a 15 mm incision and connected to the spinal cord or peripheral nerves with a thin electrical lead. Power is supplied wirelessly with an externally worn rechargeable disc, while therapy is controlled by a smartphone app. The company says its implant can...
Today's Sponsors
Today's Sponsor